Portal de Periódicos da CAPES

Revisão Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease

2015; Thieme Medical Publishers (Germany); Volume: 74; Issue: 2 Linguagem: Inglês

10.1590/0004-282x20150194

1678-4227

Juan Clinton Llerena, Osvaldo Jm Nascimento, Acary Souza Bullé Oliveira, Mário Emílio Teixeira Dourado Júnior, Carlo Domênico Marrone, Heloise Helena Siqueira, Cláudia Ferreira da Rosa Sobreira, Elza Dias‐Tosta, Lineu César Werneck,

Child Nutrition and Feeding Issues

Pompe disease (PD) is a potentially lethal illness involving irreversible muscle damage resulting from glycogen storage in muscle fiber and activation of autophagic pathways. A promising therapeutic perspective for PD is enzyme replacement therapy (ERT) with the human recombinant enzyme acid alpha-glucosidase (Myozyme®). The need to organize a diagnostic flowchart, systematize clinical follow-up, and establish new therapeutic recommendations has become vital, as ERT ensures greater patient longevity. A task force of experienced clinicians outlined a protocol for diagnosis, monitoring, treatment, genetic counseling, and rehabilitation for PD patients. The study was conducted under the coordination of REBREPOM, the Brazilian Network for Studies of PD. The meeting of these experts took place in October 2013, at L'Hotel Port Bay in São Paulo, Brazil. In August 2014, the text was reassessed and updated. Given the rarity of PD and limited high-impact publications, experts submitted their views.